Why SCHD Stands Out Among Blue Chip ETFs in 2025

In these uncertain market times, I've been gravitating toward blue chip investments that offer stability amid inflation concerns and tariff anxieties. The Schwab U.S. Dividend Equity ETF (SCHD) has caught my attention as particularly compelling.

What makes SCHD special? It's not just another dividend fund. This ETF tracks companies with at least 10 years of dividend payments - essentially filtering for businesses that have weathered multiple economic cycles. The current 3.7% yield looks particularly attractive when compared to many alternatives in today's market.

The performance numbers speak volumes: 8.81% over three years, 11.57% over five years, and an impressive 12.46% over the past decade. Even more appealing is the ridiculously low 0.06% expense ratio - you'll pay just $6 annually per $10,000 invested. That's pocket change for accessing this caliber of portfolio.

Looking at the top holdings reveals a who's who of corporate America: Chevron, ConocoPhillips, PepsiCo, Altria, AbbVie, Merck, Home Depot, Cisco, Texas Instruments, and Verizon. These aren't speculative tech darlings but established revenue generators with substantial market positions. Several offer yields exceeding 4% - with Altria and Verizon pushing above 6%.

I'm particularly drawn to the energy exposure through Chevron and ConocoPhillips, which could benefit from ongoing global supply constraints. The healthcare names (AbbVie, Merck) provide defensive positioning if economic conditions deteriorate.

However, the concentration in certain sectors might give some investors pause. Energy and consumer staples have significant representation, while technology exposure is more limited than in broader market indexes. This could mean underperformance during tech-driven rallies.

For long-term income investors seeking established businesses with proven dividend histories, SCHD offers an elegant one-stop solution. The combination of respectable growth potential and meaningful income makes this a cornerstone holding worth considering for virtually any portfolio seeking blue chip exposure.